Assyro AI

Orange Book product · Brand (NDA)

CARDENE

NICARDIPINE HYDROCHLORIDE

Brand (NDA)NDA 019734TE APRX CHIESI

At a glance

Jan 30, 1992

Approved

Brand (NDA)

Application

AP

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 30, 1992

    34 yr 11 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

NICARDIPINE HYDROCHLORIDE

Strength

25MG/10ML (2.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Dosage form

INJECTABLE

Route

INJECTION

TE code

AP

Application

NDA 019734

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.